| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Principal Accounting Officer
1 company
Dunn Edmund is a Principal Accounting Officer at Monte Rosa Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 4 sells.
Estimated insider holdings value: $445K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 5, 2026 | GLUE Monte Rosa Therapeutics, Inc. | Principal Accounting Officer | Sell | 1,039 | $15.17 | $15,761.63 | -4.4% | +17.6% | - | |
| Jun 3, 2025 | GLUE Monte Rosa Therapeutics, Inc. | Principal Accounting Officer | Sell | 2,062 | $4.45 | $9,174.46 | -8.0% | +6.0% | - | |
| Jul 5, 2024 | GLUE Monte Rosa Therapeutics, Inc. | Principal Accounting Officer | Sell | 1,610 | $3.83 | $6,166.46 | -10.4% | +40.4% | +36.5% | |
| Jun 3, 2024 | GLUE Monte Rosa Therapeutics, Inc. | Principal Accounting Officer | Sell | 1,207 | $4.04 | $4,875.80 | -7.2% | +46.2% | +16.6% |